H. Yoshida

N. Hiraoka, H. Yoshida, R. Watanabe, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Adenocarcinoma arising in sigmoid colon neovagina 53 years after construction

H. Yoshida, Y. Kanemitsu, D. Shida, 2018, World Journal of Surgical Oncology.

A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status

N. Hiraoka, H. Yoshida, K. Shimada, 2016, Virchows Archiv.

Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma.

T. Takano, A. Miyauchi, H. Yoshida, 2002, Cancer letters.

Quantitative analysis of osteonectin mRNA in thyroid carcinomas.

T. Takano, A. Miyauchi, H. Yoshida, 2002, Endocrine journal.

Overexpression of kα1 tubulin mRNA in thyroid anaplastic carcinoma

T. Takano, A. Miyauchi, H. Yoshida, 2001 .

Incidental lymphangioleiomyomatosis in the lymph nodes of gynecologic surgical specimens.

H. Yoshida, M. Ishikawa, Tomoyasu Kato, 2018, European journal of obstetrics, gynecology, and reproductive biology.

EIF3E–RSPO2 and PIEZO1–RSPO2 fusions in colorectal traditional serrated adenoma

M. Kojima, Yutaka Saito, H. Yoshida, 2019, Histopathology.

Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis

Teruhiko Yoshida, A. Ochiai, N. Hiraoka, 2017, Modern Pathology.

RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach

I. Oda, H. Katai, H. Yoshida, 2018, Modern Pathology.

Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages.

H. Yoshida, T. Yanagawa, T. Ishii, 1997, Biochemical and biophysical research communications.

c-Abl expression in oral squamous cell carcinomas.

H. Harada, H. Yoshida, K. Omura, 2000, Oral oncology.

S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2007, Anticancer research.

Induction of murine intestinal and hepatic peroxiredoxin MSP23 by dietary butylated hydroxyanisole.

K. Itoh, H. Yoshida, T. Yanagawa, 2000, Carcinogenesis.

Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Cancer letters.

Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress.

J. Seita, H. Yoshida, T. Yanagawa, 1996, Biochemical and biophysical research communications.

A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism.

T. Takano, A. Miyauchi, H. Yoshida, 2007, Endocrine journal.

Cyclooxygenase‐2 expression in thyroid neoplasms

A. Miyauchi, Y. Takamura, H. Yoshida, 2003, Histopathology.

Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.

N. Yanaihara, A. Okamoto, T. Kohno, 2021, The New England journal of medicine.

Thrombospondin 1 mRNA as a candidate for a marker to detect thyroid-derived fibroblasts in fine needle aspiration biopsy of the thyroid.

T. Takano, A. Miyauchi, H. Yoshida, 2006, Endocrine journal.

BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2014, World Journal of Surgery.

Diagnostic Discordance in Intraoperative Frozen Section Diagnosis of Ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese Cancer Center

H. Yoshida, Hiroki Tanaka, M. Ishikawa, 2020, International journal of surgical pathology.

Tumor‐associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma

N. Hiraoka, H. Yoshida, Y. Ino, 2018, Cancer science.

Abnormalities of the adenomatous polyposis coli gene in human oral squamous‐cell carcinoma

S. Seino, K. Uzawa, H. Tanzawa, 1994, International journal of cancer.

Expression and cellular localization of p8 protein in thyroid neoplasms.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Cancer letters.

Tie‐1 tyrosine kinase expression in human thyroid neoplasms

A. Miyauchi, Y. Takamura, H. Yoshida, 2004, Histopathology.

Immunohistochemical Study of Glypican 3 in Thyroid Cancer

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2008, Oncology.

Frequent MED12 mutations in phyllodes tumours of the breast

Masayuki Yoshida, T. Kinoshita, A. Ochiai, 2015, British Journal of Cancer.

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast

Masayuki Yoshida, Y. Kanai, N. Hiraoka, 2015, British Journal of Cancer.

Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report.

H. Yoshida, Kenta Takahashi, Tomoyasu Kato, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Phosphorylation of A170 stress protein by casein kinase II-like activity in macrophages.

H. Yoshida, T. Yanagawa, T. Ishii, 1997, Biochemical and biophysical research communications.

MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2009, Endocrine journal.

Expression of nestin mRNA is a differentiation marker in thyroid tumors.

Hiroya Yamada, T. Takano, A. Miyauchi, 2009, Cancer letters.

BRAFV600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas

T. Takano, A. Miyauchi, H. Yoshida, 2007, British Journal of Cancer.

Y‐box binding protein expression in thyroid neoplasms: Its linkage with anaplastic transformation

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Pathology international.

Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation.

H. Nakamine, A. Miyauchi, Yasuhiro Ito, 2004, International journal of molecular medicine.

Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis.

K. Tabuchi, H. Yoshida, T. Yanagawa, 1999, Cancer letters.

Superficially serrated adenoma: a proposal for a novel subtype of colorectal serrated lesion

Y. Oono, M. Kojima, N. Hiraoka, 2018, Modern Pathology.

Rapidly deforming gastric carcinosarcoma with osteoblastic component: an autopsy case report.

H. Yoshida, Yoshio Suzuki, N. Tochigi, 2012, World journal of gastroenterology.

S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.

Nozawa, A. Miyauchi, Yasuhiro Ito, 2005, Pathology, research and practice.

Expression of S100A2 and S100A6 in thyroid carcinomas

A. Miyauchi, H. Yoshida, C. Tomoda, 2005, Histopathology.

S100A4 Expression Is an Early Event of Papillary Carcinoma of the Thyroid

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2005, Oncology.

Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Cancer letters.

Expression of cdc25A and cdc25B proteins in thyroid neoplasms

A. Miyauchi, H. Yoshida, F. Matsuzuka, 2002, British Journal of Cancer.

High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study

E. Noguchi, T. Shimoi, K. Yonemori, 2022, BMC Cancer.

Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma

A. Miyauchi, Y. Takamura, H. Yoshida, 2004, British Journal of Cancer.

Expression of p8 protein in medullary thyroid carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Anticancer research.

Expression of Jun activation domain‐binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Pathology.

Expression of the Components of the Cip/Kip Family in Malignant Lymphoma of the Thyroid

H. Nakamine, A. Miyauchi, Yasuhiro Ito, 2004, Pathobiology.

BRIEF COMMUNICATIONS and CASE REPORTS Vet Pathol 43:353-356 (2006) Renal Adenocarcinoma in a Ferret

H. Yoshida, H. Kawaguchi, 2006 .

HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2005, Anticancer research.

Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers

H. Yoshida, K. Shiraishi, Tomoyasu Kato, 2021, Cancers.

Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.

H. Harada, H. Yoshida, K. Omura, 2005, International journal of oral and maxillofacial surgery.

High level of tumour protein p53‐induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid

A. Miyauchi, Yasuhiro Ito, J. Iovanna, 2006, Pathology.

Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2006, Anticancer research.

PATHOLOGICAL, HISTOCHEMICAL AND ULTRASTRUCTURAL STUDIES ON SEA‐BLUE HISTIOCYTES AND GAUCHER‐LIKE CELLS IN ACQUIRED LIPIDOSIS OCCURRING IN LEUKEMIA

H. Yoshida, H. Kimura, K. Terashima, 1977, Acta pathologica japonica.

Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study

A. Okamoto, K. Yoshihara, N. Matsumura, 2023, British Journal of Cancer.

Gene aberration profile of tumors of adolescent and young adult females

A. Okamoto, H. Ogiwara, T. Kohno, 2017, Oncotarget.

Clinicopathological and molecular correlations in traditional serrated adenoma

T. Ushijima, M. Kojima, Yutaka Saito, 2020, Journal of Gastroenterology.

Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.

H. Yoshida, K. Harigaya, Yoshio Suzuki, 2014, International Journal of Oncology.

Relative expression of hMena 11 a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma

H. Yoshida, K. Harigaya, Yoshio Suzuki, 2022 .

Overexpression of Human Tumor-Associated Antigen, RCAS1, Is Significantly Linked to Dedifferentiation of Thyroid Carcinoma

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2002, Oncology.

Genome-Wide Chromatin Analysis of FFPE Tissues Using a Dual-Arm Robot with Clinical Potential

T. Kohno, H. Yoshida, S. Hayami, 2021, Cancers.

Identification and Characterization of Novel Genotoxic Stress-Inducible Nuclear Long Noncoding RNAs in Mammalian Cells

A. Wakamatsu, T. Isogai, N. Akimitsu, 2012, PloS one.

KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Pathology, research and practice.

Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient Neoplasms

Masayuki Yoshida, N. Hiraoka, M. Fukayama, 2015, The American journal of surgical pathology.

Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA

N. Akimitsu, H. Yoshida, N. Imamachi, 2016, Oncogene.

Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2002, International journal of molecular medicine.

Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer.

H. Yoshida, S. Nanjo, S. Fujita, 2017, Lung cancer.

Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.

Mariko Sasaki, A. Okamoto, H. Ogiwara, 2019, Gynecologic oncology.

A case of cervical adenocarcinoma arising from endometriosis in the absence of human papilloma virus infection

H. Yoshida, Tomoyasu Kato, T. Uehara, 2019, The journal of obstetrics and gynaecology research.

Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.

Masayuki Yoshida, M. Yunokawa, T. Baba, 2018, Surgical oncology.

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.

Mariko Sasaki, A. Okamoto, H. Ogiwara, 2019, Cancer cell.

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers

Masayuki Yoshida, E. Noguchi, A. Shimomura, 2021, BMC Cancer.

Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2003, Oncology reports.

Expression of cdc25A and cdc25B phosphatase in breast carcinoma

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2004, Breast cancer.

Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.

H. Nakamine, A. Miyauchi, Yasuhiro Ito, 2003, Pathology, research and practice.

Acquisition of WNT Pathway Gene Alterations Coincides With the Transition From Precursor Polyps to Traditional Serrated Adenomas

M. Kojima, Yutaka Saito, H. Yoshida, 2019, The American journal of surgical pathology.

Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients

Y. Ohe, I. Oda, Yutaka Saito, 2017, Familial Cancer.

On-tissue polysulfide visualization by surface-enhanced Raman spectroscopy benefits patients with ovarian cancer to predict post-operative chemosensitivity

K. Iwaisako, T. Kasamatsu, M. Suematsu, 2021, Redox biology.

Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy

T. Kohno, T. Honda, J. Itami, 2021, Scientific Reports.

A patient with primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia induced by a novel germline CaSR gene mutation.

M. Hirokawa, A. Miyauchi, H. Yoshida, 2009, Asian journal of surgery.

PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.

T Takano, T. Takano, A. Miyauchi, 2004, European journal of cancer.

Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix

T. Kohno, H. Yoshida, K. Shiraishi, 2021, Cancers.

High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas

T. Takano, A. Miyauchi, H. Yoshida, 2004, British Journal of Cancer.

Gene expression profiles in thyroid carcinomas

A. Miyauchi, H. Yoshida, T. Higashiyama, 2000, British Journal of Cancer.

S 100 A 8 and S 100 A 9 Expression Is a Crucial Factor for Dedifferentiation in Thyroid Carcinoma

M. Hirokawa, A. Miyauchi, Yasuhiro Ito, 2009 .

Large‐scale Analysis of Mutations in RET Exon 16 in Sporadic Medullary Thyroid Carcinomas in Japan

A. Miyauchi, H. Yoshida, N. Amino, 2001, Japanese journal of cancer research : Gann.

Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Anticancer research.

Decreased expression of catalase mRNA in thyroid anaplastic carcinoma.

T. Takano, A. Miyauchi, H. Yoshida, 2003, Japanese journal of clinical oncology.

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives

K. Yonemori, H. Yoshida, T. Nishikawa, 2021, World journal of clinical oncology.

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma

Masayuki Yoshida, M. Yunokawa, T. Baba, 2018, Annals of Surgical Oncology.

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients

H. Yoshida, M. Ishikawa, M. Kato, 2021, Pathology & Oncology Research.

Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy

K. Yonemori, K. Ariyoshi, H. Yoshida, 2021, Virchows Archiv.

Peroxiredoxin I expression in oral cancer: a potential new tumor marker.

H. Harada, H. Yoshida, K. Omura, 2000, Cancer letters.

Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immunoglobulin heavy chain messenger ribonucleic acid.

T. Takano, A. Miyauchi, H. Yoshida, 2000, The Journal of clinical endocrinology and metabolism.

Galectin‐3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma

A. Miyauchi, Yasuhiro Ito, H. Inohara, 2005, Pathology.

Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies.

A. Miyauchi, Yasuhiro Ito, T. Yoshii, 2008, Biochemical and biophysical research communications.

Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.

T. Takano, A. Miyauchi, H. Yoshida, 2003, Cancer letters.

Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas

A. Ochiai, N. Hiraoka, Yutaka Saito, 2017, Histopathology.

Frequent PTPRK–RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma

T. Ushijima, M. Kojima, A. Ochiai, 2016, The Journal of pathology.

Requirements for implementation of artificial intelligence in the practice of gastrointestinal pathology

T. Kiyuna, H. Yoshida, 2021, World journal of gastroenterology.

Magnetic resonance imaging findings in 11 cases of dedifferentiated endometrial carcinoma of the uterus

M. Kusumoto, H. Yoshida, Haruto Sugawara, 2021, Japanese Journal of Radiology.

Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan

N. Hiraoka, H. Yoshida, K. Shimada, 2016, Virchows Archiv.

Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases.

Hiroya Yamada, M. Hirokawa, T. Takano, 2012, Endocrine journal.

Preparation of thyroid tumor cells in aspiration biopsies for aspiration biopsy nucleic acid diagnosis

Hiroya Yamada, T. Takano, A. Miyauchi, 2008, Head & neck.

Aspiration biopsy-nucleic acid diagnosis of thyroid malignant lymphoma by vectorette PCR: experience of eight cases.

T. Takano, A. Miyauchi, H. Yoshida, 2008, Leukemia research.

Detection of monoclonality of the immunoglobulin heavy chain gene in thyroid malignant lymphoma by vectorette polymerase chain reaction.

T. Notomi, T. Takano, A. Miyauchi, 2005, The Journal of clinical endocrinology and metabolism.

Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.

T. Takano, A. Miyauchi, H. Yoshida, 2002, Japanese journal of clinical oncology.

Endometrial Carcinoma With an Unusual Morphology in a Patient With Cornelia de Lange Syndrome: A Case Study.

H. Yoshida, M. Ishikawa, Tomoyasu Kato, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with huge goitrous Hashimoto’s thyroiditis

I. Shiojima, A. Miyauchi, H. Yoshida, 2019, Endocrine.

Clear Cell Carcinoma of the Cervix With OHVIRA Syndrome: A Rare Case Report

H. Yoshida, M. Ishikawa, T. Natsume, 2021, World journal of oncology.

Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer

N. Hiraoka, H. Yoshida, H. Nitta, 2020 .

The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma

A. Shimomura, T. Shimoi, M. Kodaira, 2017, International Journal of Gynecologic Cancer.

Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid.

H. Nakamine, A. Miyauchi, Yasuhiro Ito, 2004, Anticancer research.

Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2004, Thyroid : official journal of the American Thyroid Association.

Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma

H. Tsuda, I. Oda, H. Katai, 2014, Virchows Archiv.

Primary Adenocarcinoma of the Jejunum with Intramural Metastasis: Is This a Rare Event?

H. Yoshida, Yoshio Suzuki, N. Tanaka, 2012, Journal of Gastrointestinal Cancer.

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer

E. Noguchi, A. Shimomura, T. Shimoi, 2017, Cancer Chemotherapy and Pharmacology.

Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.

H. Yoshida, M. Ishikawa, Tomoyasu Kato, 2023, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Ovarian metastasis of gastrointestinal stromal tumor: A case report and review of the literatures

H. Yoshida, Mayumi Kobayashi, R. Watanabe, 2017 .

Syndecan‐1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation

A. Miyauchi, Y. Takamura, H. Yoshida, 2003, Histopathology.

Expression of p8 protein in breast carcinoma; an inverse relationship with apoptosis.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Anticancer research.

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.

A. Okamoto, T. Kohno, T. Honda, 2019, Gynecologic oncology.

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma

Masayuki Yoshida, M. Yunokawa, T. Baba, 2018, Annals of Surgical Oncology.

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy

N. Hiraoka, H. Yoshida, M. Ishikawa, 2018, Journal of gynecologic oncology.

14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Cancer letters.

Meeting Report: The International Workshop on Harmonization and Standardization of Digital Pathology Image, Held on April 4, 2019 in Tokyo

Y. Yagi, T. Kiyuna, M. Yamaguchi, 2019, Pathobiology.

Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancer

H. Yoshida, S. Nanjo, S. Fujita, 2017, Oncotarget.

Automated histological classification of whole slide images of colorectal biopsy specimens

Tomoharu Kiyuna, Eric Cosatto, Yoshiko Yamashita, 2017, Oncotarget.

Metachronous occurrence of two different histological subtypes of endometriosis-related neoplasms

H. Yoshida, Tomoyasu Kato, T. Uehara, 2018, Gynecologic oncology reports.

Details of HER2 status in 454 cases of biliary tract cancer.

N. Hiraoka, H. Yoshida, H. Nitta, 2020, Human pathology.

Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?

H. Yoshida, M. Ishikawa, Tomoyasu Kato, 2021, Virchows Archiv.

Encapsulated Anaplastic Thyroid Carcinoma Without Invasive Phenotype with Favorable Prognosis: Report of a Case

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2003, Surgery Today.

Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance

N. Miyasaka, H. Yoshida, Y. Kanemitsu, 2020, International Journal of Clinical Oncology.

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma

H. Yoshida, M. Ishikawa, Tomoyasu Kato, 2018, Journal of gynecologic oncology.

Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites.

Masayuki Yoshida, K. Tamura, M. Sone, 2020, Gynecologic oncology.

Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials

T. Kohno, Y. Fujiwara, K. Tamura, 2016, Molecular Cancer.

Delta Np73 expression in thyroid neoplasms originating from follicular cells

H. Uramoto, A. Miyauchi, Yasuhiro Ito, 2006, Pathology.

Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation

H. Yoshida, K. Shiraishi, Tomoyasu Kato, 2022, Virchows Archiv.

Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion

M. Fukayama, H. Yoshida, H. Ichikawa, 2019, Virchows Archiv.

Primary pulmonary meningioma: A rare case report of aspiration cytological features and immunohistochemical assessment

H. Yoshida, N. Motoi, A. Yoshida, 2018, Diagnostic cytopathology.

Inverse relationships between the expression of MMP‐7 and MMP‐11 and predictors of poor prognosis of papillary thyroid carcinoma

Yasuhiro Ito, Yasushi Nakamura, Akira Miyauchi, 2006, Pathology.

Gross mucinous multinodular appearance aids in the identification of ovarian metastases in low-grade appendiceal mucinous neoplasms during intraoperative consultation.

H. Yoshida, Hiroki Tanaka, M. Ishikawa, 2020, Annals of diagnostic pathology.

Endometrial Cancer Occurring 27 Years after Radiation Therapy for Cervical Carcinoma

H. Yoshida, M. Ishikawa, Mayumi Kobayashi, 2016 .

Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.

H. Nakamine, A. Miyauchi, Yasuhiro Ito, 2003, Anticancer research.

Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2005, Pathology, research and practice.

Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.

A. Miyauchi, Yasuhiro Ito, Y. Takamura, 2003, Anticancer research.

Multicenter phase II study of trastuzumab deruxtecan (DS-8201) for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.

J. Furuse, N. Hiraoka, Mitsuhito Sasaki, 2020 .

Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp

N. Hiraoka, Yutaka Saito, H. Yoshida, 2018, Histopathology.

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

Y. Ohe, E. Noguchi, A. Shimomura, 2020, Oncology letters.

Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy

T. Takano, A. Miyauchi, H. Yoshida, 2001, British Journal of Cancer.

Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management

N. Hiraoka, H. Yoshida, M. Ishikawa, 2018, Asia-Pacific journal of clinical oncology.

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study

A. Okamoto, K. Yoshihara, N. Matsumura, 2023, Cancer science.

Chemotherapy-associated foam cell aggregates as a prognostic factor in patients with pelvic high-grade serous carcinoma receiving neo-adjuvant chemotherapy

H. Yoshida, Tomoyasu Kato, I. Kuno, 2020, Virchows Archiv.

Changes in HER3 expression profiles between primary and recurrent gynecological cancers

E. Noguchi, T. Shimoi, K. Yonemori, 2023, Cancer Cell International.

Expression of TRbeta1 mRNAs with functionally impaired mutations is rare in thyroid papillary carcinoma.

T. Takano, A. Miyauchi, H. Yoshida, 2003, Journal of Clinical Endocrinology and Metabolism.

Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment

A. Miyauchi, Yasuhiro Ito, H. Yoshida, 2014, European Thyroid Journal.

Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells

Yuji Sato, H. Yoshida, H. Okuyama, 2020, AntiCancer Research.

A Primary Peritoneal Serous Carcinoma Metastasizing to the Stomach Mimicking a Submucosal Tumor: A Potential Pitfall of Clinical Diagnosis

H. Yoshida, Mayumi Kobayashi, R. Watanabe, 2016 .

Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma

H. Yoshida, T. Shimoda, K. Masutomi, 2012, Cancer science.